Invasive Breast Carcinoma
📧 Sign up to get email alerts when something new happens for Invasive Breast Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-08-28Clinical Trial Update: Testing MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer [Phase 3]
Phase 3 trial evaluating pembrolizumab (MK-3475) as adjuvant therapy for triple-negative breast cancer; currently active-not-recruiting.
-
CLINICAL_TRIALS trial_result · 2026-07-31Clinical Trial Update: Testing MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer [Phase 3]
Phase 3 trial exploring pembrolizumab as adjuvant therapy for triple-negative breast cancer is actively not recruiting.
-
CLINICAL_TRIALS trial_result · 2026-07-02Clinical Trial Update: Testing MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer [Phase 3]
Phase 3 clinical trial update for pembrolizumab as adjuvant therapy in triple-negative breast cancer, status ACTIVE_NOT_RECRUITING.
-
CLINICAL_TRIALS trial_result · 2026-07-01Clinical Trial Update: Testing MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer [Phase 3]
Phase 3 trial evaluating pembrolizumab (MK-3475) as adjuvant therapy for triple-negative breast cancer is ongoing with active status.
-
CLINICAL_TRIALS trial_result · 2026-06-25Clinical Trial Update: Testing MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer [Phase 3]
Phase 3 trial evaluating pembrolizumab (MK-3475) as adjuvant therapy for triple-negative breast cancer; ongoing ACTIVE_NOT_RECRUITING trial …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-06-03Clinical Trial Update: Testing MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer [Phase 3]
Phase 3 trial investigating pembrolizumab (MK-3475) as adjuvant therapy for triple-negative breast cancer; currently active but not recruiti…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Areola Preservation in NSM With Nipple Involvement [NA]
A clinical trial update describing a study on areola preservation during nipple-sparing mastectomy in breast cancer, including DCIS and inva…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Biospecimen and Medical Data Collection and Tumor Biopsy in Creating Research Tissue Registry in Patients With Inflammatory or Invasive Breast Cancer
This clinical trial update describes collecting biospecimens, medical data, and tumor biopsies to create a research tissue registry in patie…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Carboplatin and Paclitaxel With or Without Panitumumab in Treating Patients With Invasive Triple Negative Breast Cancer [Phase 2]
A Phase 2 clinical trial evaluates carboplatin and paclitaxel with or without panitumumab in invasive triple-negative breast cancer. The stu…
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: Tissue- and Serum-Derived Exosomal microRNAs as Predictors of Neoadjuvant Chemotherapy Response in Breast Cancer
A clinical trial investigating tissue- and serum-derived exosomal microRNAs as predictors of response to neoadjuvant chemotherapy in breast …
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: Comparing Supplemental Topical Agents for the Treatment of Acute Radiation Dermatitis in Patients With Breast Cancer [Phase 1]
Phase 1 clinical trial evaluating supplemental topical agents for the treatment of acute radiation dermatitis in patients with breast cancer…
-
CLINICAL_TRIALS research · 2026-01-05Clinical Trial Update: Metformin and Nightly Fasting in Women With Early Breast Cancer [Phase 2]
Phase 2 clinical trial update evaluating metformin combined with nightly fasting in women with early breast cancer. The study, sponsored by …
-
CLINICAL_TRIALS research · 2025-12-09Clinical Trial Update: 5 vs. 9-day Course of Whole Breast Radiotherapy With Boost for Early-stage Breast Cancer [Phase 2]
A Phase 2 study comparing 5-day versus 9-day courses of whole breast radiotherapy with a boost for early-stage breast cancer; the trial is c…
-
CLINICAL_TRIALS research · 2025-11-10Clinical Trial Update: Imlunestrant and Abemaciclib for the Treatment of Estrogen Receptor Positive Breast Cancer in Patients With Minimal Residual Disease, MIRI Trial [Phase 2]
Phase 2 trial evaluating imlunestrant in combination with abemaciclib for estrogen receptor-positive breast cancer with minimal residual dis…
-
CLINICAL_TRIALS research · 2025-10-27Clinical Trial Update: Impact of COVID-19 Pandemic on Out-of-Pocket Costs, Lost Wages, and Unemployment in Patients With Breast Cancer Undergoing Breast Surgery
A clinical trial updating on the impact of the COVID-19 pandemic on out-of-pocket costs, lost wages, and unemployment for patients with brea…
-
CLINICAL_TRIALS trial_result · 2024-02-13Clinical Trial Update: Liposomal Doxorubicin, Bevacizumab, and Everolimus in Patients With Locally Advanced TNBC With Tumors Predicted Insensitive to Standard Chemotherapy; A Moonshot Initiative [Phase 2]
Phase 2 trial evaluating liposomal doxorubicin, bevacizumab, and everolimus in locally advanced triple-negative breast cancer predicted inse…
-
CLINICAL_TRIALS trial_result · 2023-06-27Clinical Trial Update: Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer [Phase 3]
Phase 3 trial evaluating tamoxifen citrate, letrozole, anastrozole, or exemestane with or without chemotherapy in invasive breast cancer (Rx…
-
CLINICAL_TRIALS trial_result · 2022-12-06Clinical Trial Update: Bexarotene in Preventing Breast Cancer in Patients at High Risk for Breast Cancer [Phase 1]
Phase 1 trial evaluating bexarotene for preventing breast cancer in high-risk individuals; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-02-10Clinical Trial Update: Talazoparib Before Standard Therapy in Treating Patients With Invasive, BRCA-Mutated Breast Cancer [Phase 2]
Phase 2 trial update investigating talazoparib before standard therapy in invasive, BRCA-mutated breast cancer shows completed status with p…
-
CLINICAL_TRIALS trial_result · 2019-09-20Clinical Trial Update: Trametinib and Akt Inhibitor GSK2141795 in Treating Patients With Metastatic Triple-Negative Breast Cancer [Phase 2]
Phase 2 trial updates trametinib combined with an AKT inhibitor (GSK2141795) in metastatic triple-negative breast cancer; study completed wi…